Clinical Trials Browser

INDUSTRY × Adenocarcinoma of Lung × atezolizumab × Clear all

NCT04432207 2026-03-25

A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer

Phase 1 Terminated

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung